Casein as a Carrier Matrix for 5-Fluorouracil: Drug Release from Microspheres, Drug-protein Conjugates and In-vivo Degradation of Microspheres in Rat Muscle
- 1 November 1994
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 46 (11) , 858-862
- https://doi.org/10.1111/j.2042-7158.1994.tb05702.x
Abstract
Glutaraldehyde cross-linked casein microspheres were loaded with 5-fluorouracil (5-FU) from concentrated aqueous solutions of the drug after the microspheres were synthesized and cleaned. In-vitro release of the drug was examined in phosphate buffer in the absence and in the presence of protease at 37°C. Drug release data showed that only about 20% of the drug is released in the absence of protease even after 5 days, while digestion of the matrix with protease released the entrapped drug completely in about 24 h. A protein-drug conjugate was synthesized via carbamoyl linkage using 6-(5-FU-1-yl)hexyl isocyanate and the drug release was examined in phosphate buffer at 37°C. Release from the protein-5-FU conjugate was slower compared with the release from microspheres in the presence of protease. Implantation of placebo microspheres of different cross-linking densities in the gluteal muscle of rats showed no adverse tissue reactions over a one-year period. Histopathological examination of the tissues containing injected microspheres suggested that the biological life of casein microspheres in muscle is about 6 months, which is three times that of cross-linked albumin microspheres.Keywords
Funding Information
- Ministry of Science & Technology, Government of India (SP/SO/D-21/89)
This publication has 21 references indexed in Scilit:
- Doxorubicin-loaded Casein Microspheres: Protean Nature of Drug IncorporationJournal of Pharmacy and Pharmacology, 1992
- Design of poly(α‐malic acid)‐5FU conjugate exhibiting antitumor activityBritish Polymer Journal, 1990
- Haemoglobin, transferrin and albumin/polyaspartic acid microspheres as carriers for the cytotoxic drug adriamycin. I. Ultrastructural appearance and drug contentJournal of Controlled Release, 1988
- Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastasesNuclear Medicine Communications, 1987
- Chemoembolisation in regional cancer chemotherapy: a rationaleCancer Treatment Reviews, 1987
- Continued in vitro and in vivo release of an antitumor drug from albumin microspheresCellular and Molecular Life Sciences, 1983
- Preparation of Hydrophilic Albumin Microspheres Using Polymeric Dispersing AgentsJournal of Pharmaceutical Sciences, 1982
- Serum Albumin Beads: An Injectable, Biodegradable System for the Sustained Release of DrugsScience, 1981
- Drug-carrier property of albumin microspheres in chemotherapy. III. Effect of microsphere-entrapped 5-fluorouracil on ehrlich ascites carcinoma in mice.Journal of Pharmacobio-Dynamics, 1979
- Drug-carrier property of albumin microspheres in chemotherapy. I. Tissue distribution of microsphere-entrapped 5-fluorouracil in mice.CHEMICAL & PHARMACEUTICAL BULLETIN, 1977